- £509.90m
- £694.17m
- €1.67bn
- 64
- 76
- 47
- 71
Annual income statement for C&C, fiscal year end - February 28th, EUR millions except per share, conversion factor applied.
2021 February 28th | 2022 February 28th | R2023 February 28th | 2024 February 29th | 2025 February 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 737 | 1,438 | 1,686 | 1,653 | 1,666 |
| Cost of Revenue | |||||
| Gross Profit | 175 | 329 | 395 | 381 | 383 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 824 | 1,382 | 1,617 | 1,742 | 1,625 |
| Operating Profit | -86.9 | 56.5 | 68.9 | -89.6 | 40.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -121 | 45.7 | 52.2 | -112 | 19.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -105 | 37.1 | 40.3 | -114 | 13.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -105 | 37.1 | 40.3 | -114 | 13.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -105 | 37.1 | 40.3 | -114 | 13.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.197 | 0.014 | 0.144 | 0.106 | 0.142 |
| Dividends per Share |